Company Filing History:
Years Active: 1989
Title: Siegfried Hebisch: Innovator in Cardioactive Compounds
Introduction
Siegfried Hebisch is a notable inventor based in Oberhausen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cardioactive compounds. His work has implications for cardiovascular health and treatment.
Latest Patents
Siegfried Hebisch holds a patent for "Circulation-active dihydropyridine ethers." This patent describes novel dihydropyridine ethers of the formula ##STR1##, where R.sup.1 stands for cyano, nitro, or a -COOR.sup.5 group. This innovation is aimed at enhancing cardiovascular function and offers potential therapeutic benefits.
Career Highlights
Hebisch is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to engage in cutting-edge research and development in the field of pharmaceuticals. His expertise in dihydropyridine compounds has positioned him as a key figure in this area of study.
Collaborations
Throughout his career, Siegfried Hebisch has collaborated with esteemed colleagues, including Gerhard Franckowiak and Martin Bechem. These partnerships have fostered innovation and have contributed to the advancement of research in cardiovascular therapies.
Conclusion
Siegfried Hebisch's work in developing cardioactive dihydropyridine ethers showcases his commitment to improving cardiovascular health through innovative chemistry. His contributions continue to influence the pharmaceutical industry and enhance treatment options for patients.